Matches in SemOpenAlex for { <https://semopenalex.org/work/W4383217265> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W4383217265 abstract "Abstract Background Secukinumab has been approved by the U.S. FDA and the European Medicines Agency for the treatment of moderate-to-severe plaque psoriasis and psoriatic arthritis with the documented adverse effects. Here we reported in one case that a new symptom, Prurigo Nodularis (PN), developed during the programmed dosing of secukinumab. Case introduction A 22-years-old male with a 6-month history of severe plaque psoriasis vulgaris was presented to the dermatology clinic two weeks after the fifth serial weekly doses of secukinumab, for the reason of the outbreaks of multiple erythematous papules and pruritus nodules on the trunk and extremities. Physical examination showed that psoriatic rash were under effective control with the previous targeted therapy of secukinumab for plaque psoriasis vulgaris, but new dermatologic condition was spotted with multiple edematous red firm papules on the trunk and extremities, in the form of soy or hemispherical nodules, red in color, firm to touch, with some ulcerated crusts visible at tops, but negative Auspitz sign. Pathological examination confirmed these papules as PN. Conclusion This case report is shared to inform clinicians about an unannounced adverse effect of the secukinumab in the treatment of psoriasis, and it is recommended that patients be carefully informed of the possible risk of PN before starting treatment." @default.
- W4383217265 created "2023-07-06" @default.
- W4383217265 creator A5015819576 @default.
- W4383217265 creator A5019183414 @default.
- W4383217265 creator A5029304211 @default.
- W4383217265 creator A5030945438 @default.
- W4383217265 creator A5041273324 @default.
- W4383217265 creator A5048552793 @default.
- W4383217265 creator A5090743919 @default.
- W4383217265 date "2023-07-05" @default.
- W4383217265 modified "2023-09-30" @default.
- W4383217265 title "Prurigo Nodularis onset during secukinumab treatment of psoriasis: a case report" @default.
- W4383217265 cites W1491767948 @default.
- W4383217265 cites W1508752722 @default.
- W4383217265 cites W2116068128 @default.
- W4383217265 cites W2129360882 @default.
- W4383217265 cites W2212307711 @default.
- W4383217265 cites W2238074512 @default.
- W4383217265 cites W2359919307 @default.
- W4383217265 cites W2412600252 @default.
- W4383217265 cites W2499510596 @default.
- W4383217265 cites W2890967377 @default.
- W4383217265 cites W2967449819 @default.
- W4383217265 cites W3135019186 @default.
- W4383217265 cites W3137301988 @default.
- W4383217265 cites W3216802214 @default.
- W4383217265 cites W4285719527 @default.
- W4383217265 cites W4288073636 @default.
- W4383217265 cites W96516359 @default.
- W4383217265 doi "https://doi.org/10.1186/s13223-023-00811-5" @default.
- W4383217265 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37408052" @default.
- W4383217265 hasPublicationYear "2023" @default.
- W4383217265 type Work @default.
- W4383217265 citedByCount "2" @default.
- W4383217265 countsByYear W43832172652023 @default.
- W4383217265 crossrefType "journal-article" @default.
- W4383217265 hasAuthorship W4383217265A5015819576 @default.
- W4383217265 hasAuthorship W4383217265A5019183414 @default.
- W4383217265 hasAuthorship W4383217265A5029304211 @default.
- W4383217265 hasAuthorship W4383217265A5030945438 @default.
- W4383217265 hasAuthorship W4383217265A5041273324 @default.
- W4383217265 hasAuthorship W4383217265A5048552793 @default.
- W4383217265 hasAuthorship W4383217265A5090743919 @default.
- W4383217265 hasBestOaLocation W43832172651 @default.
- W4383217265 hasConcept C126322002 @default.
- W4383217265 hasConcept C16005928 @default.
- W4383217265 hasConcept C197934379 @default.
- W4383217265 hasConcept C2776260265 @default.
- W4383217265 hasConcept C2776266956 @default.
- W4383217265 hasConcept C2779121184 @default.
- W4383217265 hasConcept C2779786854 @default.
- W4383217265 hasConcept C2780564577 @default.
- W4383217265 hasConcept C71924100 @default.
- W4383217265 hasConceptScore W4383217265C126322002 @default.
- W4383217265 hasConceptScore W4383217265C16005928 @default.
- W4383217265 hasConceptScore W4383217265C197934379 @default.
- W4383217265 hasConceptScore W4383217265C2776260265 @default.
- W4383217265 hasConceptScore W4383217265C2776266956 @default.
- W4383217265 hasConceptScore W4383217265C2779121184 @default.
- W4383217265 hasConceptScore W4383217265C2779786854 @default.
- W4383217265 hasConceptScore W4383217265C2780564577 @default.
- W4383217265 hasConceptScore W4383217265C71924100 @default.
- W4383217265 hasFunder F4320336578 @default.
- W4383217265 hasIssue "1" @default.
- W4383217265 hasLocation W43832172651 @default.
- W4383217265 hasLocation W43832172652 @default.
- W4383217265 hasLocation W43832172653 @default.
- W4383217265 hasOpenAccess W4383217265 @default.
- W4383217265 hasPrimaryLocation W43832172651 @default.
- W4383217265 hasRelatedWork W2195057011 @default.
- W4383217265 hasRelatedWork W2601256796 @default.
- W4383217265 hasRelatedWork W2895404113 @default.
- W4383217265 hasRelatedWork W2904527393 @default.
- W4383217265 hasRelatedWork W2920791236 @default.
- W4383217265 hasRelatedWork W2951098817 @default.
- W4383217265 hasRelatedWork W3101847676 @default.
- W4383217265 hasRelatedWork W3194750073 @default.
- W4383217265 hasRelatedWork W4224235547 @default.
- W4383217265 hasRelatedWork W4292534228 @default.
- W4383217265 hasVolume "19" @default.
- W4383217265 isParatext "false" @default.
- W4383217265 isRetracted "false" @default.
- W4383217265 workType "article" @default.